Skip to main content

Consultation: Medicinal cannabis cost recovery framework

Consultation period
Last updated

This consultation closed on 20 March 2020.

Invitation to comment

The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework.


Discussion paper released for consultation on Tuesday, 10 March 2020.

Submissions close at 5:00pm on Friday, 20 March 2020.

Feedback will be released following consideration of submissions (see What will happen)

About the consultation

The ODC, over a period of 6 months, has undertaken a comprehensive review of the Medicinal Cannabis Cost Recovery Framework. The ODC has hosted six engagements sessions in the period November 2019 through to February 2020 to share preliminary findings and seek feedback. The Discussion Paper presents the findings of that review, summarises the changes that the ODC proposes to make to the Medicinal Cannabis Cost Recovery Framework and seeks further feedback from stakeholders.

The Discussion Paper and invitation for written submissions continues the public consultation.

Content of submissions

Submissions may address any, or all of the matters contained in the Discussion Paper.

The ODC is particularly interested in your feedback on the introduction of:

  • the permit modification request fee
  • a licence charge and a site charge
  • follow up charges for audit, inspection and sampling
  • the enforcement charges.

In providing feedback, please provide examples of circumstance in which you think the application of these fees and charges may be problematic or ask specific questions about how the fees or charges would be applied to your specific circumstances.

How to submit

Please complete the online consultation submission form to upload your submission in either pdf or word format.

Consultation submission form

Alternatively, submissions in either pdf or word format, along with the Consultation Submission Cover Sheet, can be provided directly to the ODC via


Any questions relating to submissions should be directed to the ODC by email at or by telephone to 02 6289 4606.

What will happen

All submissions will be placed on this website unless marked confidential or indicated otherwise in the submission form (see Privacy information).

Feedback collated through this consultation process will be taken into account prior to finalising a brief to the Minister for Health, seeking approval for changes.

Privacy information

The ODC collects your personal information in this submission in order to:

  • contact you if we would like to seek clarification of any issues raised in your submission or to check whether you consent to certain information that you have provided being made publicly available; and
  • help provide context about your submission, e.g. to determine whether you are an individual or a director of a company or representing an interest group.
  • Seek feedback about how the consultation was undertaken.

Please do not include personal information about other individuals in the body of your submission. Personal information in this context means information or an opinion about an individual whose identity is apparent, or can reasonably be ascertained, from the information or opinion.

More information on privacy can be found on our website.

Help us improve the Office of Drug Control site